Bio Rad Laboratories, Inc. financial data

Symbol
BIO, BIO-B on NYSE
Industry
Laboratory Analytical Instruments
Location
1000 Alfred Nobel Drive, Hercules, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 605 % +10%
Quick Ratio 155 % +21.7%
Debt-to-equity 40.9 % -0.41%
Return On Assets -11.4 % -241%
Operating Margin 13 % -1.52%

Shares

Label TTM Value / Value Unit Change %
Weighted Average Number of Shares Outstanding, Basic 28.4M shares -3.27%
Weighted Average Number of Shares Outstanding, Diluted 28.4M shares -3.27%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.56B USD -7.45%
Research and Development Expense 233M USD -14.8%
Operating Income (Loss) 332M USD -8.87%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.73B USD -225%
Income Tax Expense (Benefit) -404M USD -291%
Net Income (Loss) Attributable to Parent -1.33B USD -209%
Earnings Per Share, Basic -47 USD/shares -216%
Earnings Per Share, Diluted -47 USD/shares -214%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 407M USD +4.34%
Accounts Receivable, after Allowance for Credit Loss, Current 446M USD -9.37%
Inventory, Net 804M USD +3.49%
Other Assets, Current 32.4M USD +63.5%
Assets, Current 3.06B USD -2.63%
Property, Plant and Equipment, Net 529M USD +6.1%
Operating Lease, Right-of-Use Asset 181M USD +4.34%
Intangible Assets, Net (Excluding Goodwill) 307M USD -6.58%
Goodwill 412M USD +0.15%
Other Assets, Noncurrent 94.9M USD +0.27%
Assets 9.69B USD -19.1%
Accounts Payable, Current 127M USD -15.3%
Employee-related Liabilities, Current 132M USD -14.4%
Liabilities, Current 487M USD -16.3%
Long-term Debt and Lease Obligation 1.2B USD +0.11%
Deferred Income Tax Liabilities, Net 878M USD -37.3%
Operating Lease, Liability, Noncurrent 151M USD +2.81%
Other Liabilities, Noncurrent 194M USD -4.33%
Liabilities 2.91B USD -17.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -451M USD -21.1%
Retained Earnings (Accumulated Deficit) 7.48B USD -15.1%
Stockholders' Equity Attributable to Parent 6.78B USD -19.7%
Liabilities and Equity 9.69B USD -19.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 69.8M USD -28.9%
Net Cash Provided by (Used in) Financing Activities 4.31M USD -99.6%
Net Cash Provided by (Used in) Investing Activities -43.1M USD +38.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 29.4M USD -1.92%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 408M USD +4.41%
Interest Paid, Excluding Capitalized Interest, Operating Activities 22.4M USD -0.25%
Deferred Tax Assets, Valuation Allowance 53.2M USD -26.9%
Deferred Tax Assets, Gross 264M USD -1.75%
Operating Lease, Liability 193M USD +5.02%
Payments to Acquire Property, Plant, and Equipment 40.2M USD +12.5%
Lessee, Operating Lease, Liability, to be Paid 219M USD +6.16%
Property, Plant and Equipment, Gross 1.6B USD +5.82%
Operating Lease, Liability, Current 41.5M USD +13.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 36.2M USD +1.12%
Lessee, Operating Lease, Liability, to be Paid, Year One 47.7M USD +21.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +31.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 26.3M USD +15.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 28.1M USD +1.08%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 7.5M shares
Unrecognized Tax Benefits 87.1M USD -4.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 21.7M USD -0.91%
Operating Lease, Payments 42.7M USD +8.93%
Additional Paid in Capital 475M USD +0.18%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 22.7M USD -6.2%
Deferred Tax Assets, Net of Valuation Allowance 211M USD +7.61%
Interest Expense 49.3M USD +2.65%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares